The four start-ups that will be receiving €60,000 ($50,000) in funding and mentoring via Bayer’s Grants4Apps Accelerator programme have been revealed. They are New York-based Oratel Diagnostics, which has developed a non-invasive test to detect endometriosis; London firm Aparito, which combines wearable technology, an app and a dashboard to improve data capture during clinical trials; South Korean firm Sky Labs, which has developed a device that diagnoses atrial fibrillation; and ThinkSono from London, which uses software to diagnose deep vein thrombosis.
The four start-ups that will be receiving €50,000 ($60,000) in funding and mentoring via Bayer’s Grants4Apps Accelerator programme have been revealed. They are New York-based Oratel Diagnostics, which has developed a non-invasive test to detect endometriosis; London firm Aparito, which combines wearable technology, an app and a dashboard to improve data capture during clinical trials; South Korean firm Sky Labs, which has developed a device that diagnoses atrial fibrillation; and ThinkSono from London, which uses software to diagnose deep vein thrombosis.